scispace - formally typeset
A

Allen Izu

Researcher at Novartis

Publications -  27
Citations -  5725

Allen Izu is an academic researcher from Novartis. The author has contributed to research in topics: Vaccination & Immunogenicity. The author has an hindex of 17, co-authored 27 publications receiving 3661 citations. Previous affiliations of Allen Izu include Chiron Corporation.

Papers
More filters
Journal ArticleDOI

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Merryn Voysey, +81 more
- 09 Jan 2021 - 
TL;DR: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
Journal ArticleDOI

Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.

TL;DR: Analysis of data from a randomized, double-blind, placebo-controlled trial of an ineffective candidate HSV-2 vaccine suggests that identification of discordant couples can reduce transmission of HSv-2, especially for heterosexual couples in which the male partner has HSV -2 infection.
Journal ArticleDOI

Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo-Controlled Vaccine Trial

TL;DR: The monthly rate of recurrences was not significantly improved, but the duration and severity of the first study outbreak was reduced significantly by vaccination, and Glycoprotein-specific and neutralizing antibodies were boosted by vaccination for the duration of the study.
Journal ArticleDOI

The Relationship between Condom Use and Herpes Simplex Virus Acquisition

TL;DR: The effect of condom use on HSV acquisition in this prospectively followed cohort of men and women was analyzed and it was found that frequent condom use is associated with a lower rate of acquisition of HSV-2.